REVIEW PAPER
Advanced hybrid closed loop on the Polish market
1
Department of Children’s Diabetology Medical University of Silesia, Katowice, Poland
2
Students’ Scientific Association at the Department of Children’s Diabetology, Medical University of Silesia, Katowice, Poland
Submission date: 2022-04-05
Final revision date: 2022-06-29
Acceptance date: 2022-06-29
Publication date: 2022-12-30
Pediatr Pol 2022;97(4):334-336
KEYWORDS
TOPICS
ABSTRACT
Since 1921, when Frederick Banting and Charles Best discovered insulin, we have observed rapid development in the field of diabetology. On the one hand, it is associated with clinical research on the aetiopathogenesis of metabolic disorders, and on the other hand, with the development of new technologies such as devices for insulin delivery and glycaemia monitoring. Since December 2020, the Medtronic MiniMed™ 780G system has been available in Poland. This is the first advanced hybrid closed loop personal insulin pump on the domestic market. It uses advanced algorithms to maintain glucose levels at a predetermined threshold by combining information from continuous glucose monitoring, which enables automatic estimation of basal insulin dose and automatic correction combined with manual initiation of meal boluses.
REFERENCES (16)
1.
Poretsky L. Principles of diabetes mellitus. Princ Diabetes Mellit. https://link.springer.com/book....
2.
Diabetes THEA. Implications of the diabetes control and complications trial. Diabetes Care 2003; 26: 25-27.
3.
McAdams B, Rizvi A. An overview of insulin pumps and glucose sensors for the generalist. J Clin Med 2016; 5: 5.
4.
Alsaleh FM, Smith FJ, Keady S, et al. Insulin pumps: from inception to the present and toward the future. J Clin Pharm Ther 2010; 35: 127-138.
7.
Petrovski G, Al Khalaf F, Campbell J, et al. 10-day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes. Acta Diabetol 2020; 57: 681-687.
9.
O’Neill S. Update on technologies, medicines and treatments including Libre 3, MiniMed 780G and Glucomen Day continuous glucose monitoring. Diabet Med 2021; 38:.
11.
McVean J, Miller J. MiniMedTM 780G insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy. Expert Rev Med Devices 2021; 18: 499-504.
13.
Christiansen MP, Garg SK, Brazg R, et al. Accuracy of a fourth-generation subcutaneous continuous glucose sensor. Diabetes Technol Ther 2017; 19: 446-456.
14.
Lepore G, Battelino T, Arrieta A, et al. Real- world performance of the MiniMedTM 780G system: first report of outcomes from 4120 users. Diabetes Technol Ther 2022; 24: 113-119.
15.
Petrovski G, Al Khalaf F, Campbell J, et al. The effect of advanced hybrid closed loop system on glycated hemoglobin (HbA1c) in a young male with type 1 diabetes mellitus and growth hormone treatment: a case report. Clin Case Reports 2021; 9: 1-5.
16.
Petrovski G, Campbell J, Almajali D, et al. Virtual training on advanced hybrid closed‐loop system MiniMed 780G in a teenager with type 1 diabetes previously treated with multiple daily injections: A case report. Clin Case Reports 2021; 9: 1-5.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
